Wolfgang Schulte

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 259 citations · Full text

Medicine, Genetics, Oncology +17

<i>MET</i> Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

Hans‐Ulrich Schildhaus, Anne M. Schultheis, Josef Rüschoff et al. · Clinical Cancer Research · 2014 · 189 citations

Medicine, Genetics, Oncology +17

<i>PIK3CA</i> mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

Matthias Scheffler, Marc Bos, Masyar Gardizi et al. · Oncotarget · 2014 · 145 citations · Full text

Medicine, Genetics, Oncology +17

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

Hans‐Ulrich Schildhaus, Lukas C. Heukamp, Sabine Merkelbach‐Bruse et al. · Modern Pathology · 2012 · 130 citations · Full text

Medicine, Molecular Biology, Oncology +16

Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients

Sebastian Michels, Andreas H. Scheel, Matthias Scheffler et al. · Journal of Thoracic Oncology · 2016 · 98 citations · Full text

Medicine, Cancer Biology, Oncology +11